Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-25 @ 1:47 AM
NCT ID:
NCT04788394
Eligibility Criteria:
Inclusion Criteria:
All pediatric patients with COVID-19 were admitted to Hamad Hospital from (0 to 14) years, using the electronic medical records (Cerner), over that time period (from March 1, to January 1, 2021), with one of the following:
* Proteinuria: (≥1+) on dipstick analysis.
* Hematuria: ≥ 5 RBC/HPF.
* Sterile Pyuria: ≥ 5 WBC/HPF or ≥10 WBC/mm3 with negative urine culture (44).
* Hypernatremia :\> 145meq/l.
* Hyponatremia: \< 135 meq/l.
* Hypokalemia :\< 3.5meq/l.
* Metabolic acidosis (ph \<7.35).
* Elevated serum creatinine :\> upper limit of reference interval (ULRI) values.
* Elevated serum urea: \> 7 mmol/l.
* Urine specific gravity (SG) \<1.003.
Exclusion Criteria:
\* Patient with previous chronic kidney diseases.
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
14 Years
Study:
NCT04788394
Study Brief:
Protocol Section:
NCT04788394